Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeoka Shinji is active.

Publication


Featured researches published by Takeoka Shinji.


Journal of Controlled Release | 1989

Control of release of encapsulated molecules from polymerized mixed liposomes induced by physical or chemical stimuli

Takeoka Shinji; Ohno Hiroyuki; Hayashi Narutoshi; Tsuchida Eishun

Abstract Small unilamellar mixed liposomes composed of polymerizable and non-polymerizable lipids are polymerized to prepare stimuli-responsive polymerized liposomes. Encapsulated 5(6)-carboxyfluorescein (CF) is released from non-polymerizable regions by physical and/or chemical stimuli. As the liposome structure is maintained by polymerized lipid frames, the release is stopped by removing the stimuli. This process can be repeated several times. CF is released rapidly at the phase transition temperature of the non-polymerizable lipids, e.g., at 37 and 19°C for dipalmitoylphosphatidylcholine and dimyristoylphosphatidykholine, respectively. The temperature dependence is further affected by the size of the phase-separated domains. Polymerized mixed liposomes having larger phase-separated domains show a sharper response to the phase transition. In case of polymerized mixed liposomes containing phosphatidylethanolamine, CF is released as a function of pH. The release rate is very small at pH 11, but it increases with pH decreasing to 7.5, which is attributed to the structural change of the bilayer induced by the change in dissociation of the head groups. On the other hand, in case of polymerized mixed liposomes containing phosphatidylserine, release of CF is accelerated by the addition of Ca 2+ ions and is restored to the initial rate by eliminating Ca 2+ ions with ethylenediamine tetraacetic acid sodium salt (EDTA). The CF release response is obtained repeatedly by the alternating addition of Ca 2+ ion and EDTA.


Archive | 2004

PHARMACEUTICAL COMPOSITION CONTAINING ARTIFICIAL OXYGEN TRANSPORTER

Kai Toshiya; Katayama Naohisa; Azuma Yoshiko; Yokoe Junichi; Kida Yoshinori; Fukutomi Ippei; Sato Makoto; Tsuchida Hidetoshi; Takeoka Shinji; Komatsu Teruyuki; Sakai Hiromi; So Keitaro


Archive | 2003

AMPHOTERIC IONIC LIPID AND APPLICATION OF THE SAME

Tsuchida Hidetoshi; Takeoka Shinji; So Keitaro; Mori Katsura


Archive | 2006

Künstlicher Sauerstoffträger und Herstellungsverfahren dafür

Tsuchida Eishun; Takeoka Shinji; Komatsu Teruyuki; Kai Toshiya; Katayama Naohisa; Fukutomi Ippei; Sato Makoto


Archive | 2006

ARTIFICIAL OXYGEN CARRIER CONTAINING METHEMGLOBIN FORMATION INHIBITOR

Takeoka Shinji; Tsuchida Hidetoshi; Sakai Hiromi; Teramura Yuji; Ahei Tomoyasu


Archive | 2004

STABLY PRESERVABLE OXYGEN TRANSFUSION

Tsuchida Hidetoshi; Sakai Hiromi; Tomiyama Kenichi; Takeoka Shinji; So Keitaro


Archive | 2010

LIPID VOM CARBONSÄURETYP

Tsuchida Eishun; Takeoka Shinji; Sou Keitaro; Ohkawa Haruki; Mori Katsura


Archive | 2009

METHODE ZUR PHOTOREDUKTION VON HÄMOGLOBIN-VESIKELN

Tsuchida Eishun; Sakai Hiromi; Onuma Hiroto; Takeoka Shinji


Archive | 2008

PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EINEN KÜNSTLICHEN SAUERSTOFFTRÄGER

Kai Toshiya; Katayama Naohisa; Azuma Yuko; Yokoe Junichi; Kida Yoshinori; Hukutomi Ippei; Sato Makoto; Tsuchida Eishun; Takeoka Shinji; Komatsu Teruyuki; Sakai Hiromi; So Keitaro


Archive | 2007

VEHICULO DE OXIGENO ARTIFICIAL Y SU METODO DE PRODUCCION.

Tsuchida Eishun; Takeoka Shinji; Komatsu Teruyuki; Kai Toshiya; Katayama Naohisa; Fukutomi Ippei

Collaboration


Dive into the Takeoka Shinji's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge